The MONET trial: week 144 analysis of the efficacy of darunavir/ritonavir (DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load < 50 HIV-1 RNA copies/mL at baseline-Reference-Cited by-同舟云学术

The MONET trial: week 144 analysis of the efficacy of darunavir/ritonavir (DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load < 50 HIV-1 RNA copies/mL at baseline

Published:2012-03-14 Issue:7 Volume:13 Page:398-405
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Arribas JR¹,Clumeck N²,Nelson M³,Hill A⁴,Delft Y⁵,Moecklinghoff C⁶

Affiliation:

1. University Hospital La Paz; IdiPAZ; Madrid; Spain

2. St Pierre Hopital; Brussels; Belgium

3. St Stephens Centre; Chelsea and Westminster Hospital; London; UK

4. Pharmacology Research Laboratories; University of Liverpool; Liverpool; UK

5. Janssen EMEA; Tilburg; the Netherlands

6. Janssen EMEA; Neuss; Germany

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2012.00989.x/fullpdf

Reference24 articles.

1. Antiretroviral treatment of Adult HIV infection. 2008 recommendations of the International AIDS Society-USA panel;Hammer;JAMA,2008

2. US Department for Health and Social Security Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents 2011 www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?GuidelineID=7

3. European AIDS Clinical Society (EACS) Guidelines for the clinical management of HIV infected adults in Europe 2011 www.europeanaidsclinicalsociety.org/%20guidelinespdf/1_Treatment_of_HIV_Infected_Adults.pdf

4. GESIDA Expert Panel and the National AIDS Plan GESIDA consensus document/Spanish AIDS plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection] 2011 www.gesida.seimc.org/pcientifica/dcconsensos.asp

5. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml;Arribas;AIDS,2010

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term efficacy and safety of a treatment strategy for HIV infection using protease inhibitor monotherapy: 8-year routine clinical care follow-up from a randomised, controlled, open-label pragmatic trial (PIVOT);eClinicalMedicine;2024-03

2. Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials;The Lancet HIV;2024-02

3. The Effectiveness of Different Doses or Types of Vitamin D Supplementation in HIV-Positive Individuals in Lahore;Pakistan Journal of Health Sciences;2023-04-30

4. Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance;eLife;2023-03-15

5. Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus;Medicine;2022-12-09